ACM
GSK icon

Alta Capital Management’s GSK GSK Stock Holding History

Alta Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,430
Closed -$1.04M – 80
2017
Q4 		$1.04M Buy
23,430
+959
+4% +$44.3K 0.07% 55
2017
Q3 		$1.14M Buy
22,471
+962
+4% +$48.8K 0.07% 55
2017
Q2 		$1.16M Buy
21,509
+455
+2% +$24.3K 0.08% 53
2017
Q1 		$1.11M Buy
21,054
+562
+3% +$28.5K 0.07% 56
2016
Q4 		$986K Buy
20,492
+50
+0.2% +$2.47K 0.07% 60
2016
Q3 		$1.1M Buy
20,442
+1,668
+9% +$91.5K 0.07% 59
2016
Q2 		$1.02M Buy
18,774
+772
+4% +$40.7K 0.06% 59
2016
Q1 		$912K Buy
18,002
+55
+0.3% +$2.74K 0.06% 60
2015
Q4 		$905K Sell
17,947
-1,221
-6% -$62.2K 0.07% 61
2015
Q3 		$921K Sell
19,168
-1,616
-8% -$84.1K 0.08% 64
2015
Q2 		$1.08M Sell
20,784
-1,939
-9% -$109K 0.09% 62
2015
Q1 		$1.31M Buy
22,723
+1,469
+7% +$84.2K 0.11% 59
2014
Q4 		$1.14M Sell
21,254
-919
-4% -$51.4K 0.09% 62
2014
Q3 		$1.27M Buy
22,173
+1,219
+6% +$74.7K 0.12% 56
2014
Q2 		$1.4M Sell
20,954
-1,395
-6% -$94.4K 0.13% 56
2014
Q1 		$1.49M Buy
22,349
+200
+0.9% +$13.5K 0.14% 51
2013
Q4 		$1.48M Buy
22,149
+2,423
+12% +$157K 0.15% 52
2013
Q3 		$1.24M Buy
19,726
+1,308
+7% +$84.2K 0.15% 49
2013
Q2 		$1.15M Buy
+18,418
New +$1.17M 0.16% 50

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alta Capital Management's GSK Position: Q1 2018 in Review

Alta Capital Management sold out of GSK (GSK) in Q1 2018, closing a stake of 23,430 shares — an estimated $1.04M sold.

Alta Capital Management first reported a position in GSK in Q2 2013 and held it in 19 quarters. The position peaked at $1.49M in Q1 2014. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • Alta Capital Management reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • Alta Capital Management sold 23,430 GSK shares in Q1 2018, an estimated $1.04M.
  • Alta Capital Management first reported a position in GSK in Q2 2013 and held it in 19 quarters.
  • Alta Capital Management's GSK position peaked at $1.49M in Q1 2014.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Alta Capital Management's 13F filing for Q1 2018, filed 6 Apr 2018.